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Abstract 
Medicinal plants are recognized from ancient times as a source of diverse therapeutic 
agents and many of them are used as dietary supplements.  Comprehensive approaches 
are needed that would identify bioactive components with evident activity against 
specific indications and provide a better link between science (ethno-botany, chemistry, 
biology and pharmacology) and market. Recently, the bark of black alder (Alnus 
glutinosa) appeared at market in the form of food supplement for treatment of different 
skin conditions. This study aimed to evaluate protective effects of two diarylheptanoids 
isolated from the bark of black alder: platyphylloside - 5(S)-1,7-di(4-hydroxyphenyl)-3-
heptanone-5-O-β-D-glucopyranoside (1) and its newly discovered analog 5(S)-1,7-di(4-
hydroxyphenyl)-5-O-β-D-[6-(E-p-coumaroylglucopyranosyl)]heptane-3-one (2) towards 
doxorubicin damaging activity. To that end, we employed HaCaT cells, non-cancerous 
human keratinocytes commonly used for skin regenerative studies. Diarylheptanoids 
significantly antagonized the effects of doxorubicin by lowering the sensitivity of HaCaT 
cells to this drug. Compound 2 prevented doxorubicin-induced cell death by activating 
autophagy. Both 1 and 2 protected HaCaT cells against doxorubicin-induced DNA 
damage. They significantly promoted migration and affected F-actin distribution. These 
results indicate that chemo-protective effects of diarylheptanoids may occur at multiple 
subcellular levels. Therefore, diarylheptanoids 1 and 2 could be considered as protective 
agents for non-cancerous dividing cells during chemotherapy. 
 
Keywords 
diarylheptanoid; curcumin; doxorubicin; DNA damage; cell motility; chemoprotection 
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Introduction 
For approximately 85% of the world’s population, plant materials are a primary 
source of health care [1]. Natural products drug discovery could be beneficial for the 
major lethal diseases such as cancer, as there are still no satisfactory drug treatments. 
Besides food, plant products and extracts are widely used as spices, cosmetics and 
pharmaceutical agents [2]. Our attention was drawn by the plants from the Alnus genus 
well known for their traditional medicinal values. These plants have been used for the 
treatment of various diseases including cancer. Particularly, we were interested in the 
bark of black alder (Alnus glutinosa) because of its beneficial effects on different skin 
problems [3]. 
Many products from the bark of black alder currently on the market are used as 
food supplements to treat different chronic dermatological conditions. However, they are 
still not approved by the Food and Drug Administration (FDA) and extensive studies of 
chemically defined bioactive components present in such supplements are needed. 
While other Alnus species have been widely studied, there are few reports 
describing the secondary metabolites found in the seeds and bark of Alnus glutinosa [4-
7].  
Diarylheptanoids are common phenolic compounds consisting of two aromatic 
rings connected by a heptane chain abundant in the Alnus species [8-9], but also found in 
Zingiber, Curcuma, Alpinia and Betula genera. Curcumin is the most investigated 
diarylheptanoid isolated from Curcuma longa (Zingiberaceae) with a wide range of 
biological activities [10-14]. Diarylheptanoids have been shown to exhibit antioxidative 
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[15-16], anti-inflammatory [17], antiviral [18], cytotoxic [19-21], or anti-cancer effects 
[22]. Recently, we reported that diarylheptanoids from the bark of Alnus glutinosa 
possess chemo-protective activity in human lymphocytes DNA [6]. Moreover, they were 
able to protect the integrity of mitochondria and increase antioxidant capacity of normal 
cells [23]. 
Herein we further investigated dermo-protective actions of diarylheptanoids from 
the bark of black alder using human normal keratinocytes. The effects were assessed on a 
subcellular level, including the effects on DNA damage, autophagy and cell motility. 
 
 
Materials and methods 
Drugs 
Doxorubicin (DOX) solution was obtained from EBEWE Arzneimittel GmbH, 
Vienna, Austria. Curcumin (CUR) was purchased from Sigma-Aldrich Chemie GmbH, 
Germany and diluted in absolute ethanol. AZD2014 was a kind gift from SelleckChem, 
Houston, TX, USA. Diarylheptanoids 1 and 2 were isolated from A. glutinosa bark as 
described previously [6]. The yield of compounds 1 and 2 are 0.33% and 0.033%, 
respectively (calculated on extract) or 0.08% and 0.008% respectively (calculated on dry 
plant material) [6]. 
 
Chemicals 
RPMI 1640 medium, DMEM medium, penicillin–streptomycin solution, 
antibiotic–antimycotic solution, L-glutamine and trypsin/EDTA were purchased from 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 5 
PAA, Vienna, Austria. Fetal bovine serum (FBS), dimethyl sulfoxide (DMSO) and 
Hoechst 33342 were obtained from Sigma–Aldrich Chemie GmbH, Germany. Bovine 
serum albumin was from Serva, Heidelberg, Germany, and Triton™ X-100 from Merck 
KGaA, Darmstadt, Germany. Propidium Iodide (PI) and Annexin-V-FITC (AV) were 
purchased from Abcam, Cambridge, UK. ActinRed™ 555 was obtained from Molecular 
Probes
®
, Invitrogen Life Technologies, CA, USA. Anti-LC3B antibody was from Abcam 
(Cambridge, UK). Phospho-histone H2A.X antibody was from Cell Signaling 
Technology Inc. (Danvers, Massachusetts, USA) and secondary antibody Alexa Fluor 
488 goat anti-Rabbit IgG(H+L) was purchased from Invitrogen Life Technologies. 
 
Cell culture 
HaCaT cell line (human normal keratinocytes obtained from CLS - Cell Lines 
Service, Eppelheim, Germany) was a generous gift from Prof. Andra Jorg, Division of 
Biophysics, Research Center Borstel, Leibniz-Center for Medicine and Biosciences, 
Borstel, Germany. 518A2 melanoma cell line was obtained from the American Type 
Culture Collection, Rockville, MD, USA. Both cell lines were cultured in DMEM 
supplemented with 10% FBS, 4 g/L glucose, L-glutamine (2 mM) and 5000 U/ml 
penicilin, 5 mg/mL streptomycin solution.  
 
Cytotoxicity by MTT assay 
Cell viability was assessed by MTT assay (MTT, Sigma, St. Louis, MO). Briefly, 
cells were seeded in 96-well microplates and treated with increasing concentrations of 1, 
2, CUR and DOX for 72 h. For combination treatments, cells were pretreated with 5 μM 
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of 1, 2 or CUR at 37 °C for 6 h and subsequently treated with increasing concentrations 
of DOX. The absorbance of formazan dye was measured at 540 nm using an automatic 
microplate reader (LKB 5060-006 Micro Plate Reader, Vienna, Austria). 
Growth inhibition (I) was determined according to the following equitation: 
 
where A is absorbance. 
IC50 value was defined as a concentration of each drug that inhibited cell growth by 50%. 
IC50 was calculated by linear regression analysis using Excel software. 
 
Median effect analysis 
The nature of the interaction between different drugs was analyzed using 
CalcuSyn software (Biosoft, Cambridge, UK) that uses the combination index (CI) 
method [24], based on the multiple drug effect equation. Values of log10 (CI) < 0 point to 
a pronounced additive effect or synergism, log10 (CI) = 0 indicates an additive effect, 
and log10 (CI) > 0 points to an antagonistic effect.  
 
Cell death detection  
The percentages of apoptotic, necrotic and viable cells were determined by 
Annexin-V-FITC (AV) and propidium iodide (PI) labeling. HaCaT cells were incubated 
overnight in 6-well plates and subjected to single treatments with 5 μM 1, 2 and CUR. In 
combined treatments, cells were pretreated with 5 μM 1, 2 or CUR at 37 °C for 6 h and 
subsequently treated with 40 nM DOX. After 72 h, the attached and floating cells were 
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collected by centrifugation. AV/PI staining was performed according to manufacturer’s 
instructions and cells were analyzed within 1 h by flow-cytometry. The fluorescence 
intensity (green FL1-H and red FL2-H) was measured on FACSClibur flow-cytometer 
(Becton Dickinson, Oxford, United Kingdom). In each sample, 10,000 cells were 
recorded (gated to exclude cell debris), and the percentages of viable (AV- PI-), early 
apoptotic (AV+ PI-), apoptotic and necrotic (AV+ PI+), and already dead (AV- PI+) cells 
were analyzed by CellQuest Pro data analysis software. 
 
Fluorescence microscopy 
HaCaT cells were seeded in chamber-slides (Nunc, Naperville, IL, USA) and 
allowed to grow at 37°C overnight before treatment. Subsequently, the cells were treated 
with 5 μM 1 and 2 for 18 h at 37 °C. 250 nM AZD2014, which induces autophagy by 
inhibiting the mTOR complex, was used as a positive control. To detect autophagosomes, 
cells were washed in PBS, fixed in 4% paraformaldehyde, and blocked for 60 min with 
2% bovine serum albumin in 0.3% Triton™ X-100 in PBS.  Rabbit anti-LC3B antibody 
was applied at 1:1000 dilution in PBS/0.3% Triton X-100 and cells were incubated over 
night at 4°C. After washing in PBS, secondary antibody Alexa Fluor 488 goat anti-Rabbit 
IgG(H+L) was applied at 1:1000 dilution in PBS/0.3% Triton X-100 for 120 min at room 
temperature. Nuclei were counterstained with Hoechst 33342 for 15 min at room 
temperature and cells were mounted in Mowiol. HaCaT cells were examined under the 
Zeiss Axiovert fluorescent microscope (Carl Zeiss Foundation, Oberkochen, Germany) 
using AxioVision4.8 software.  
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To evaluate the effect of diarylheptanoids on the cytoskeleton structure, HaCaT 
cells were treated with 5 μM 1, 2 and CUR for 24 h at 37 °C. After treatment, cells were 
washed in PBS, fixed in 4% paraformaldehyde and labeled for 30 min at room 
temperature with ActinRed™ 555 which binds to F-actin. Nuclei were counterstained 
with Hoechst 33342 for 15 min at room temperature and cells were examined under the 
Zeiss Axiovert fluorescent microscope. 
To detect DNA damage, HaCaT cells were labeled with phospho-histone H2A.X 
(Ser
139
) antibody. This antibody detects endogenous levels of phosphorylated H2AX 
which is recruited to sites of double strand DNA breaks. Prior to immunostaining, cells 
were subjected to single treatments with 20 nM DOX or 5 μM 1, 2 and CUR for 18 h at 
37 °C. In combined treatments, cells were pretreated with 5 μM 1, 2 and CUR at 37 °C 
for 6 h and subsequently treated with 20 nM DOX for additional 18 h. After treatment, 
cells were washed in PBS, fixed in 4% paraformaldehyde, and blocked for 60 min with 
2% bovine serum albumin in 0.3% Triton™ X-100 in PBS.  Rabbit anti-phospho-histone 
H2A.X antibody was applied at 1:1000 dilution in PBS/0.3% Triton X-100 and cells were 
incubated over night at 4°C. After washing in PBS, secondary antibody Alexa Fluor 488 
goat anti-Rabbit IgG(H+L) was applied at 1:1000 dilution in PBS/0.3% Triton X-100 for 
120 min at room temperature. Nuclei were counterstained with Hoechst 33342 for 15 min 
at room temperature and cells were mounted in Mowiol. The cells were examined under 
the Zeiss Axiovert fluorescent microscope. 
 
Detection of autophagic flux by flow cytometry 
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The fluorescence intensity of anti-LC3B antibody coupled with secondary antibody 
Alexa Fluor 488 goat anti-Rabbit IgG(H+L) was used to assess autophagic flux by flow-
cytometric analysis. HaCaT cells were incubated overnight in 6-well plates, and then 
subjected to treatments with 5 μM 1, 2 and CUR or 250 nM AZD2014 for 18 h at 37 °C. 
Adherent cells were harvested by trypsinization, washed twice in PBS, fixed in 4% 
paraformaldehyde for 10 min at room temperature. HaCaT cells were then permeabilized 
by adding ice-cold 90% methanol and stored at -20 °C overnight. After washing in PBS, 
cells were blocked for 60 min with 0.5% bovine serum albumin in PBS. Cells were then 
resuspended in 100 μl of primary antibody diluted in 0.5% bovine serum albumin 
(1:1000) and incubated 60 min at room temperature.  After washing in PBS, cells were 
resuspended in 100 μl of fluorochrome-conjugated secondary antibody (1:1000) and 
incubated for 30 min at room temperature. HaCaT cells were subsequently washed and 
resuspended in 500 μl of PBS. The fluorescence intensity (FL1-H channel) was measured 
on FACSClibur flow-cytometer (Becton Dickinson, Oxford, United Kingdom). A 
minimum of 10,000 events were assayed for each sample. 
 
Detection of double strand DNA breaks by flow cytometry 
The fluorescence intensity of anti-phospho-histone H2A.X antibody coupled with 
secondary antibody Alexa Fluor 488 goat anti-Rabbit IgG(H+L) was used to quantify 
double strand DNA breaks by flow-cytometric analysis. HaCaT cells were incubated 
overnight in 6-well plates, and then subjected to single treatments with 20 nM DOX or 5 
μM 1, 2 and CUR for 18 h at 37 °C. In combined treatments, HaCaT cells were pretreated 
with 5 μM 1, 2 and CUR at 37 °C for 6 h and subsequently treated with 20 nM DOX for 
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additional 18 h. Adherent cells were harvested by trypsinization, washed twice in PBS, 
fixed in 4% paraformaldehyde for 10 min at room temperature. Anti-phospho-histone 
H2A.X antibody staining for flow cytometry was performed in the same manner as 
previously described anti-LC3B antibody staining. The fluorescence intensity (FL1-H 
channel) was measured on FACSClibur flow-cytometer (Becton Dickinson, Oxford, 
United Kingdom). A minimum of 10,000 events were assayed for each sample. 
 
Wound healing assay 
 HaCaT cells were seeded in 24-well plates and grown for 24 h at 37ºC. Upon 
reaching confluence, a uniform wound was scratched into a monolayer of each well with 
a sterile plastic 200 μL micropipette tip. After wounding, tissue culture medium was 
replaced and cells were treated with 5 μM diarylheptanoids 1, 2 and CUR. Wound 
closure was monitored by imaging cells at 2x magnification on a Leica microscope 
(Leica Microsystems GmbH, Wetzlar, Germany) at the moment of wounding and at 24 h 
post-wounding. The captured images were analyzed by ImageJ software (NIH, USA) to 
measure the degree of closure of the wounded area. 
 
Statistical analysis 
 The differences between groups were examined by Student’s t-test (Statistica 6.0 
software) and one-way or two-way ANOVA test (GraphPad Prism software). Statistical 
significance was accepted if p<0.05.  
 
Results and discussion 
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Diarylheptanoids 1 and 2 antagonize the effects of DOX in human normal keratinocytes 
In this study, we were focused on dermo-protective effects of diarylheptanoids 
from Alnus glutinosa. To that end, we used human normal keratinocytes (HaCaT) as a 
model for our investigation. In our previous search for naturally occurring anti-cancer 
agents with low toxicity towards normal cells, we distinguished two diarylheptanoids 
with such characteristics: platyphylloside (1) and its recently discovered analog with p-
coumaroyl group (2) (Fig. 1A) [7, 23]. Therefore, we compared the growth inhibitory 
effects of 1, 2, curcumin (CUR) and doxorubicin (DOX) in human melanoma (518A2) 
and HaCaT cells. The effects were analyzed after 72 h by MTT assay. The results are 
summarized as IC50 values and shown in Table 1. Although DOX was efficient in 
nanomolar range showing stronger anti-cancer potential, it was not selective towards 
melanoma cells since the IC50 values for DOX obtained in 518A2 and HaCaT cells were 
24.5 nM and 6.7 nM, respectively. Similarly, diarylheptanoid 1 and CUR were non-
selective, but in micromolar range, while compound 2 induced more prominent growth 
inhibition in melanoma cells with IC50 values 24 μM for 518A2 and 35.2 μM for HaCaT 
(Table 1).  
Knowing that diarylheptanoids from the bark of black alder possess cyto- and 
nucleo-protective effects [6, 23], we wondered whether 1 and 2 may protect HaCaT cells 
which are significantly sensitive to DOX. In order to study the interaction of each 
diarylheptanoid with DOX, we applied these drugs subsequently. Namely, after 6 h 
pretreatment with 1 or 2, HaCaT cells were incubated for additional 72 h with different 
concentrations of DOX. Diarylheptanoids 1 and 2 desensitized HaCaT cells to DOX by 
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increasing its IC50 values in combined treatments (Fig. 1B). The activity of these 
compounds was compared next to CUR, a well investigated diarylheptanoid with 
multiple therapeutic properties. We revealed that CUR was less protective against DOX 
in HaCaT cells.  The results obtained with combinations were then analyzed by CalcuSyn 
software to assess the nature of the interaction between two different drugs 
(synergism/antagonism). All combinations with 1 or 2 and DOX demonstrated 
pronounced antagonistic effect. The observed antagonism was less apparent when CUR 
was applied (Fig. 1C).  
 
Diarylheptanoid 2 prevents cell death induced by DOX in human normal keratinocytes 
Next, we studied the mechanisms by which diarylheptanoids from the bark of 
black alder exert their DOX-antagonistic effects in HaCaT cells. Apoptosis induction is a 
main mechanism of action in most chemotherapeutic agents including DOX [25-27], 
However, cytotoxicity exhibited by DOX on normal cells is an adverse side effect during 
the course of chemotherapy in cancer patients. 
To study the effect of compounds 1 and 2 on cell death, HaCaT cells treated with 
diarylheptanoids alone or in subsequent combination with DOX were subjected to 
Annexin-V-FITC/Propidium Iodide staining (Fig. 2A). Flow cytometry analysis revealed 
cell death-inducing activity of 40 nM DOX (11% of cells in apoptosis and 11% of cells in 
late apoptosis and necrosis). After the treatment with 5 μM of 1 the percentage of 
apoptotic HaCaT cells increased compared to untreated control (from 4% to 19%). 
Diarylheptanoid 1 combined with DOX reduced the percentage of late apoptotic and 
necrotic cells observed when 40 nM DOX was applied alone (Fig. 2A). Diarylheptanoid 
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2 did not induce cell death and completely prevented DOX effect in normal keratinocytes 
(Fig. 2A). By this means, both diarylheptanoids, particularly diarylheptanoid 2, showed 
the potential for DOX-protective action. Quantification and statistical analysis of the 
results obtained by flow cytometry for each condition is shown in Fig. 2B.   
 
 
Diarylheptanoid 2 promotes autophagy in human normal keratinocytes 
 In addition to apoptosis, the effect of compounds 1 and 2 on the autophagy 
process was also examined in HaCaT cells. Apoptosis and autophagy are not independent 
processes, and many stress pathways activate both autophagy and apoptosis within the 
same cell. Autophagy is a defense mechanism which involves degradation and recycling 
of intracellular components as a response to stress [28]. Depending on cell type and 
physiological conditions, autophagy has a dual role in cellular homeostasis, both 
promoting cell survival and apoptosis [29-30]. Normally, autophagy prevents the 
induction of apoptosis, and vice versa apoptosis-related activation of caspases inhibits the 
autophagic process [31]. 
LC3B, the ubiquitin-like protein microtubule-associated protein-1 light chain 3, is 
an essential mediator of autophagosome formation [32]. The key step in autophagosome 
biogenesis is the conversion of the unconjugated form LC3B-I to its 
phosphatidylethanolamine (PE)-conjugated and membrane-associated form LC3B-II [33-
34]. LC3B-II is integrated in the outer autophagosome membrane until the the late stages 
of autophagy, when it’s recycled by ATG4B, whereas LC3B-II on the inner membrane is 
degraded by lysosomal activity after autophagosome–lysosome fusion [32].  
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Autophagic vesicles labeled with anti-LC3B antibody were visualized in HaCaT 
cells after 18 h exposure to 5 μM CUR, 1 and 2 (Fig. 2C).  The effects of investigated 
agents were compared next to 250 nM AZD2014, mTOR inhibitor and an autophagy 
inducing agent used as a positive control. Similar to AZD2014, diarylheptanoid 2 
triggered the activation of the autophagy pathway and caused the formation of 
autophagosomes in the cytoplasm of HaCaT cells. Treatments with 1 and CUR did not 
lead to the appearance of autophagic vesicles (Fig. 2C). This supports our previous 
finding that 2, which possess a p-coumaroyl group is more selective towards cancer cells 
and more beneficial for normal cells than its related diarylheptanoid 1 [7]. 
Flow cytometry is a sensitive and precise method for analyzing autophagic flux in 
cells as LC3B-II protein serves as a potential autophagic substrate for degradation [35-
37]. Consequently, any changes in total intracellular LC3B fluorescence intensity 
represent autophagic activity in cells. Increased autophagic flux results in a continuous 
delivery of LC3B-II to autophagolysosome where this protein undergoes degradation by 
lysosomal enzymes. Enhanced autophagic flux is detected as a decrease in total cellular 
signal of fluorescently labeled LC3B. On contrary, inhibition of autophagic flux leads to 
accumulation of non-degraded LC3B and increases intracellular LC3B signal. 
HaCaT cells were treated for 18 h with 5 μM diarylheptanoids or 250 nM 
AZD2014, fixed and labeled with anti-LC3B antibody (Fig. 2D). Flow cytometry 
analysis showed a decline in overall LC3B content in cells treated with compound 2, 
similarly to AZD2014 treatment. Interestingly, compound 1 increased the cytosolic pool 
of LC3B but did not promote autophagosome formation, while curcumin treatment had 
no significant effect on LC3B levels in HaCaT cells (Fig. 2D). Quantification and 
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statistical analysis of flow-cytometric measurements of autophagic flux after treatment 
with diarylheptanoids is shown in Fig. 2E.  
Since apoptosis and autophagy can be activated by common upstream signals and 
share molecular components that directly regulate both processes, the onset of autophagy 
induced by 2 might be responsible for the reduced apoptosis observed in DOX-exposed 
cells. 
 
Diarylheptanoids 1 and 2 protect human normal keratinocytes against DOX-induced 
DNA damage 
It was previously reported that compounds 1 and 2 exhibit in vitro chemo-
protective effect on chromosome aberrations induced by clastogenic agent mitomycin C 
in peripheral human lymphocytes [6]. Studies have shown that CUR can exhibit both 
protective and damaging effects on human DNA [38-41]. On the other side, DOX is a 
DNA-intercalating agent which inhibits macromolecular biosynthesis [42]. One of its 
main mechanisms of action is the negative effect on the topoisomerase II progression, 
whose role is to relax DNA supercoils for transcription [43]. Another effect of DOX is 
the eviction of histones from chromatin which disturbs the regulation of DNA damage 
response in DOX-treated cells [44]. DOX induces the phosphorylation of histone H2AX 
on Ser
139
 (γH2AX) and DNA damage foci formation [45-47]. 
To examine the effects of diarylheptanoids on double strand DNA breaks, HaCaT 
cells were incubated for 18 h with 5 μM 1, 2 or CUR and 20 nM DOX in single and 
combination treatments. Single treatments with 1, 2 or CUR did not cause a significant 
amount of double strand DNA breaks in HaCaT cells nuclei compared to DOX damaging 
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activity (Fig. 3A). Pretreatments with 1 and 2 resulted in a major reduction of genomic 
DNA damage induced by a single DOX treatment. Co-incubation with CUR did not alter 
the effect of DOX (Fig. 3A). Double strand DNA breaks labeled with anti-phospho-
histone H2A.X antibody were quantified by flow cytometry analysis. DOX treatment in 
HaCaT cells pretreated with diarylheptanoids 1 and 2 did not generate prominent DNA 
damage observed after single treatment with doxorubicin (Fig. 3B). Moreover, single 
treatment with compound 2 further reduced the amount of double strand DNA breaks 
found in untreated cells (Fig. 3B). While single treatment with CUR also decreased DNA 
breakage compared to untreated cells, it did not manage to overcome the damaging effect 
of DOX. Quantification and statistical analysis of phosphorylated histone H2AX detected 
by flow cytometry is presented in Fig. 3C. We previously reported that 1 and 2 cause the 
retention of DOX in the cytoplasm of HaCaT cells [23]. In order to reach its target 
molecules, DNA and topoisomerase II, DOX needs to enter the nucleus, therefore this 
finding may contribute the mechanisms behind DNA protection by diarylheptanoids. 
Although diarylheptanoids 1 and 2 display multiple DOX-protective effects in 
vitro, the presence of glycosidic moiety could potentially interfere with their absorption 
in vivo. Nevertheless, there are various methods to amplify the bioavailability, ensure 
longer circulation, better permeability, and resistance to metabolic processes of orally or 
topically administered compounds [48]. Application of nanoparticles, liposomal, 
cyclodextrin or polylactic-co-glycolic acid encapsulation, and co-administation with 
other agents could all potentially improve systematic delivery of drugs such as curcumin 
[48]. Undoubtedly, further experiments are needed to address DOX-protective actions of 
investigated diarylheptanoids in in vivo model systems. 
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Diarylheptanoids 1 and 2 promote wound healing and rearrange F-actin in human 
normal keratinocytes 
Human skin consists of various cell types including keratinocytes, melanocytes, 
and fibroblasts [49]. HaCaT are human immortalized keratinocyte cells, which play an 
essential role in epidermal tissue regeneration. This cell line underwent a spontaneous 
transformation to cells which possess the characteristics of basal epidermal keratinocytes, 
and can be delivered in deep burns. For this reason, HaCaT cell line represents a very 
useful model for highly proliferative epidermis in pathological skin conditions and has 
been included in multiple wound healing, transplantation, and cell culture studies [50-54]. 
In this investigation, we used wound healing assay to address the influence of 1, 2 
and CUR on HaCaT cell migration. HaCaT cells were treated with 5 μM 1 or 2 and cell 
migration was compared to 5 μM CUR treatment after 24 h (Fig. 4A). While CUR 
showed no significant effect on cell motility, compounds 1 and 2 promoted wound 
healing in HaCaT cells (Fig. 4B). Other authors findings regarding CUR migration 
effects were contradictory: negative impact on migration was shown in lung cancer cells 
[55-56], while stimulation of proliferation and migration was detected in olfactory 
unsheathing cells [57]. 
Next, we followed whether the changes in cell motility after diarylheptanoids 
treatment could be accompanied by the formation of podosomes and lamellipodia in 
HaCaT cells. For that purpose, we labeled HaCaT cells with ActinRed™ 555 and 
visualized the actin cytoskeleton under the fluorescent microscope after treatments with 5 
μM of 1, 2 and CUR for 24 h (Fig. 4C). Our results showed that compounds 1 and 2 
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promoted podosome and lamellipodia formation besides cell migration and wound 
healing in HaCaT cells. Although 5 μM CUR did not significantly influence cell motility 
after 24 h, it exhibited a prominent effect on actin morphology in HaCaT cells, similarly 
to diarylheptanoids 1 and 2 (Fig. 4C).  
 
Conclusion 
In the search for anti-cancer agents from natural sources, two types of beneficial 
compounds may be identified: the ones with the capacity to inhibit the cancer cell growth 
and the others with protective properties in normal cells during the course of 
chemotherapy. Anti-cancer agents such as DOX induce DNA breakage, reactive oxygen 
species (ROS) formation, and apoptosis in both cancer and non-cancerous dividing cells. 
We found that diarylheptanoids isolated from the bark of black alder (Alnus glutinosa) 
may provide protection to normal cells reducing their sensitivity to the damage generated 
by DOX application. Considering the observed effect on the keratinocyte motility, the 
application of diarylheptanoids could be a promising approach for further dermo-
protection and skin regeneration studies. However, additional research is required to 
establish diarylheptanoids, particularly compound 2, as protective agents for non-
cancerous dividing cells during chemotherapy of cancer patients. 
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Figure legends 
Fig. 1. Diarylheptanoids 1 and 2 desensitize HaCaT cells to DOX.  
(A) Chemical structures of diarylheptanoids 1, 2 and CUR. (B) IC50 values for DOX after 
pretreatment with 5 μM diarylheptanoids 1, 2 and CUR in HaCaT cells. (C) The effects 
of subsequent combinations of 5 μM diarylheptanoids 1, 2 or CUR with DOX in HaCaT 
cells. The effects were assessed by MTT assay after 72 h. The nature of interactions 
between compounds was analyzed by CalcuSyn software and presented as log10 (CI) 
values. All combinations of 1 and 2 with DOX exhibited antagonistic effect (log10 (CI) > 
0). 
Fig. 2. Diarylheptanoid 2 prevents cell death induced by DOX in HaCaT cells by 
promoting autophagy. 
(A) Cell death induction by 5 μM 1 or 2 in single and combined treatments with 40 nM 
DOX in HaCaT cells. The samples were analyzed for green fluorescence (Annexin-V-
FITC, FL1-H) and red fluorescence (Propidium Iodide, FL2-H) by flow-cytometry. (B) 
Quantification and statistical analysis of flow-cytometric cell death measurements in 
HaCaT cells. Statistical analysis was performed by two-way ANOVA test. Statistical 
significance between untreated and treated samples is presented as p<0.01 (**) and 
p<0.05 (*). Statistical significance between DOX treatment and combination treatments 
is presented as p<0.05 (#). (C) Induction of autophagy in HaCaT cells. Accumulation of 
autophagosomes (green) in the cytoplasm after treatments with 5 μM of 1, 2 and CUR 
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was visualized by anti-LC3B antibody staining. HaCaT cells were treated with 250 nM 
mTOR inhibitor AZD2014, an autophagy-inducing agent as a positive control. Scale bar 
= 100 μm. (D) Flow-cytometric profiles of HaCaT cells treated with with 5 μM of 1, 2 
and CUR or 250 nM AZD2014 and labeled with anti-LC3B antibody to detect autophagic 
flux. (E) Quantification and statistical analysis of flow-cytometric autophagic flux 
measurements in HaCaT cells. Statistical significance was determined by one-way 
ANOVA test and is presented as p<0.001 (***) and p<0.01 (**). 
Fig. 3. Diarylheptanoids protect HaCaT cells against DOX-induced DNA damage. (A) 5 
μM diarylheptanoids 1, 2 and CUR were applied in single and combined treatments with 
20 nM DOX. Double strand DNA breaks were labeled with phospho-histone H2A.X 
antibody (red). Nuclei were counterstained with Hoechst 33342 (blue). Scale bar = 100 
μm. (B) Flow-cytometric profiles of HaCaT cells after single diarylheptanoid treatments 
and combined treatments with DOX. Cells were labeled with anti-phospho-histone 
H2A.X antibody to detect double strand DNA breaks. (C) Quantification and statistical 
analysis of flow-cytometric measurements of double strand DNA breaks in HaCaT cells. 
Statistical analysis was performed by one-way ANOVA test. Statistical significance 
between untreated and treated samples is presented as p<0.001 (***), p<0.01 (**) and 
p<0.05 (*). Statistical significance between DOX treatment and combination treatments 
is presented as p<0.001 (###), p<0.01 (##). 
Fig. 4. Diarylheptanoids promote wound healing and rearrange F-actin in HaCaT cells. 
(A) The effect of 24 h treatment with 5 μM 1, 2 and CUR on wound healing in HaCaT 
cells. (B) Measurement of HaCaT cell migration. The y-axis represents relative wound 
closure compared to untreated sample. Statistical significance between treated and 
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untreated cells was determined by Student's t-test and is presented as p<0.001 (***) and 
p<0.05 (*). (C) Treatment with 5 μM 1, 2 and CUR for 24 h causes formation of 
podosomes and lamellipodia in HaCaT cells. F-actin was visualized by ActinRed™ 555 
staining (green). Nuclei were counterstained with Hoechst 33342 (blue). Scale bar = 100 
μm. 
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Table 1. Cell growth inhibitory effects of diarylheptanoids 1, 2, CUR, and a classic 
chemotherapeutic agent DOX in normal human keratinocytes (HaCaT) and melanoma 
cells (518A2). Data shown are means ± s. e. m. Statistical significance was determined by 
two-way ANOVA test and is presented as p<0.001 (***) and p<0.01 (**). 
 
 
 
 
Drugs IC50 (μM) 
 HaCaT 518A2 
1 9.2 ± 1.15 15.78 ± 1.31 *** 
2 35.17 ± 1.22 24 ± 1.19 ** 
CUR 7.44 ± 1.15 48.32 ± 1.39 *** 
DOX 0.0067 ± 0.00127 0.0245 ± 0.00125 *** 
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